BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1177982)

  • 41. [The value of the concentration of carcinoembryonal antigen (CEA) in the plasma in first diagnoses and course control of treated gastrointestinal neoplasms].
    Auer IO; Münch L; Schmid L
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():1016-20. PubMed ID: 1029166
    [No Abstract]   [Full Text] [Related]  

  • 42. [Carcinoembryonic antigen (CEA) in ascites].
    Coenen C; Schmidt G; Wegener M; Wedmann B; Bauer KH; Ricken D
    Fortschr Med; 1991 Apr; 109(13):280-2. PubMed ID: 2066045
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Ganglioside and carcinoembryonic antigens in the diagnosis of malignant tumors of the gastrointestinal tract].
    Ivanov PK; Samoĭlenko VM
    Vopr Onkol; 1984; 30(9):55-9. PubMed ID: 6495695
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carcinoembryonic antigen (CEA). Use and limitations of the CEA radioimmunoassay in the diagnosis and follow-up of colo-rectal carcinoma.
    Mach JP; Pusztaszeri G; MacDonald D; Bertholet MM
    Johns Hopkins Med J Suppl; 1974; 3():369-79. PubMed ID: 4421371
    [No Abstract]   [Full Text] [Related]  

  • 45. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
    Tappero G; Piantino P; Cerchier A; Pecchio F
    Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical and prognostic value of determining the carcinoembryonic antigen].
    Vlakhov N; Dimitrova S; Koev Ch
    Khirurgiia (Mosk); 1987 Sep; (9):20-1. PubMed ID: 3695245
    [No Abstract]   [Full Text] [Related]  

  • 47. Carcinoembryonic antigen (CEA). A prospective clinical trail in patients with gastrointestinal cancer.
    Kjaer M; Fischerman K
    Scand J Gastroenterol Suppl; 1976; 37():99-106. PubMed ID: 1064149
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carcinoembryonic antigen. Quantitative variations in circulating levels in benign and malignant digestive tract diseases.
    Zamcheck N
    Adv Intern Med; 1974; 19():413-33. PubMed ID: 4592719
    [No Abstract]   [Full Text] [Related]  

  • 49. [The concentration of carcinoembryonic antigen and carbohydrate antigen Ca-19-9 in the blood serum in cancerous diseases of the gastrointestinal tract].
    Mit'kov VV; Ogneva TV; Goriaĭnova II; Milanov S; Milkov V
    Med Radiol (Mosk); 1989 Nov; 34(11):22-4. PubMed ID: 2586258
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The combined use of CA 19-9 and carcino-embryonic antigen (CEA) in malignancies of the gastrointestinal tract.
    Staab HJ
    Acta Gastroenterol Belg; 1987; 50(1):29-35. PubMed ID: 3480668
    [No Abstract]   [Full Text] [Related]  

  • 51. Immunochemical studies of the intramolecular heterogeneity of the carcinoembryonic antigen (CEA) of the human digestive system.
    Gold JM; Banjo C; Freedman SO; Gold P
    J Immunol; 1973 Dec; 111(6):1872-9. PubMed ID: 4127301
    [No Abstract]   [Full Text] [Related]  

  • 52. Serum CEA in normal individuals and in clinical disorders.
    Booth SN; King J; Leonard J; Dykes PW
    Ann Immunol (Paris); 1973 Nov; 124(4):631-2. PubMed ID: 4792502
    [No Abstract]   [Full Text] [Related]  

  • 53. [Relapse prognosis for patients with adenocarcinoma of the gastrointestinal tract on the basis of carcinoembryonic antigen (CEA) and its circulating immune complexes (author's transl)].
    Staab HJ; Anderer FA; Stumpf E; Fischer R
    Klin Wochenschr; 1980 Feb; 58(3):125-33. PubMed ID: 7366126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [New diagnostic methods: the CEA test].
    Lutz D
    ZFA (Stuttgart); 1978 Aug; 54(22):1134-6. PubMed ID: 685409
    [No Abstract]   [Full Text] [Related]  

  • 55. Screening with gastric CEA.
    Straus EW
    Gastroenterology; 1979 Aug; 77(2):427. PubMed ID: 447056
    [No Abstract]   [Full Text] [Related]  

  • 56. [The clinical value of the plasma CEA level for postoperative detection of recurrence and metastases of carcinoma of the gastrointestinal tract (author's transl)].
    Auer IL; Schmid L; Hoecht B; Kaufner G; Leclerq R
    Med Klin; 1977 May; 72(21):934-41. PubMed ID: 875869
    [No Abstract]   [Full Text] [Related]  

  • 57. [Determination of the carcinoembryonic antigen titer using radioimmunoassay in patients with malignant tumors of the gastrointestinal tract before and after surgical treatment in Belgrade].
    Dugalić D; Dordević G; Milicević M
    Acta Chir Iugosl; 1977; 24(3):251-60. PubMed ID: 607723
    [No Abstract]   [Full Text] [Related]  

  • 58. [Radioimmunologic determination of carcinoembryonic antigen (CEA). Current viewpoints and personal experience].
    Lupo A
    Minerva Dietol Gastroenterol; 1978; 24(2):89-96. PubMed ID: 733032
    [No Abstract]   [Full Text] [Related]  

  • 59. [The CEA test and other immunological tests as disease course controls in gastrointestinal adenocarcinoma].
    Hasler E; Spengler A; Berchtold R; Brunner KW; de Weck A
    Schweiz Med Wochenschr; 1977 Nov; 107(47):1683-91. PubMed ID: 929129
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunology and gastrointestinal cancer.
    Segal HL
    N Y State J Med; 1973 Nov; 73(22):2662-4. PubMed ID: 4132595
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.